enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Express Scripts offers new formulary for lower list-price drugs

   www.aol.com/news/express-scripts-offers...

   Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying rebates ...

3. Federal Trade Commission sues largest drug middlemen for ...

   www.aol.com/federal-trade-commission-sues...

   The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that prioritizes high rebates from drug ...

4. Express Scripts sues FTC over drug pricing report - AOL

   www.aol.com/news/express-scripts-sues-ftc-over...

   NEW YORK (Reuters) -Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that ...

5. Express Scripts - Wikipedia

   en.wikipedia.org/wiki/Express_Scripts

   Published annually since 1993, the Express Scripts Drug Trend Report provides detailed analysis of prescription drug costs and utilization. [ 20 ] [ 58 ] Now a web-based version, the Drug Trend Report is developed and published by the Express Scripts Research & New Solutions Lab with contributors from researchers, clinicians and others. [ 59 ]

6. Pharmacy benefit management - Wikipedia

   en.wikipedia.org/wiki/Pharmacy_benefit_management

   In 2012 Express Scripts acquired rival Medco Health Solutions for $29.1 billion and became "a powerhouse in managing prescription drug benefits". [42] As of 2015, Express Scripts Holding Company was the largest pharmacy benefit management organization in the United States. [43]

7. Specialty drugs in the United States - Wikipedia

   en.wikipedia.org/wiki/Specialty_drugs_in_the...

   According to the 2014 Express Scripts Drug Trend Report, [51] the most significant increase in prescription drugs in the United States in 2014 was due to "increased inflation and utilization of hepatitis C and compounded medications". [51] "Excluding those two therapy classes, overall drug spend would have increased only 6.4%. [51]